Reuters - The experimental weight-loss drug lorcaserin may spur modest weight loss without the heart risks of some older drugs, a new clinical trial confirms -- though whether the medication will ever reach the market remains up in the air.
Source: http://us.rd.yahoo.com/dailynews/rss/weightloss/*http://news.yahoo.com/s/nm/20110831/hl_nm/us_obesity_drug
iphone 4g iphone 4 news i phone 5
Keine Kommentare:
Kommentar veröffentlichen